MEG3 and non-small cell lung carcinoma: Lv et al. exhibited that in non-small cell lung cancer, high MEG3 levels elevated miR-21-5p and PTEN expressions and inhibited cellular migration and invasion via the miR-21 5p/PTEN axis [36].